With biggest weight loss data in hand, Eli Lilly races to start trio of PhIII trials for its ‘triple-G’ candidate next month
Eli Lilly is revving the engines for the next stage of the weight loss drug revolution with a trio of large Phase III studies set …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
